AVTE NASDAQ
Aerovate Therapeutics, Inc.
1W: -3.2%
1M: +5.9%
3M: +4.3%
1Y: -87.4%
3Y: -82.0%
$2.68
Last traded 2025-04-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-189M
Net Income
-235.4% YoY
$-107M
Free Cash Flow
-62.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-58.9%
ROA-54.3%
ROIC-43.8%
Valuation
P/E-0.0
P/B0.4
EV/EBITDA-34.6
Leverage
Debt/Equity0.00
Current Ratio14.93
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z107.25
Beneish M0.00